NDC 52747-711 Integra F

Ferrous Fumarate And Polysacchride Iron Complex And Folic Acid Capsule Oral - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
52747-711
Proprietary Name:
Integra F
Non-Proprietary Name: [1]
Ferrous Fumarate And Polysacchride Iron Complex And Folic Acid
Substance Name: [2]
Ascorbic Acid; Ferrous Asparto Glycinate; Ferrous Fumarate; Folic Acid; Niacin
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Labeler Name: [5]
    U.s. Pharmaceutical Corporation
    Labeler Code:
    52747
    Marketing Category: [8]
    UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
    Start Marketing Date: [9]
    04-27-2009
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Navigator:

    Product Characteristics

    Color(s):
    RED (C48326 - MAROON BODY AND CAP)
    Shape:
    CAPSULE (C48336)
    Size(s):
    18 MM
    Imprint(s):
    INTEGRA;F;US
    Score:
    1

    Product Packages

    NDC Code 52747-711-30

    Package Description: 30 CAPSULE in 1 BOTTLE, PLASTIC

    Price per Unit: $0.50171 per EA

    NDC Code 52747-711-60

    Package Description: 90 CAPSULE in 1 BOTTLE, PLASTIC

    Price per Unit: $0.50171 per EA

    Product Details

    What is NDC 52747-711?

    The NDC code 52747-711 is assigned by the FDA to the product Integra F which is a human prescription drug product labeled by U.s. Pharmaceutical Corporation. The generic name of Integra F is ferrous fumarate and polysacchride iron complex and folic acid. The product's dosage form is capsule and is administered via oral form. The product is distributed in 2 packages with assigned NDC codes 52747-711-30 30 capsule in 1 bottle, plastic , 52747-711-60 90 capsule in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Integra F?

    INDICATIONS: Integra FTM is indicated for the treatment of iron deficiency anemia, and folate deficiency anemia. Integra FTM is indicated in pregnancy for the prevention and treatment of iron deficiency and to supply a maintenance dosage of folic acid.

    What are Integra F Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • ASCORBIC ACID 40 mg/1 - A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant.
    • FERROUS ASPARTO GLYCINATE 62.5 mg/1
    • FERROUS FUMARATE 62.5 mg/1
    • FOLIC ACID 1 mg/1 - A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.
    • NIACIN 3 mg/1 - A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.

    Which are Integra F UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Integra F Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    What is the NDC to RxNorm Crosswalk for Integra F?

    RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
    • RxCUI: 999823 - ascorbic acid 40 MG / ferrous fumarate 191 MG / folic acid 1 MG / niacinamide 3 MG / polysaccharide iron complex 136 MG Oral Capsule
    • RxCUI: 999823 - vitamin C 40 MG / Ferrous fumarate 191 MG / folate 1 MG / Niacinamide 3 MG / Polysaccharide iron complex 136 MG Oral Capsule
    • RxCUI: 999823 - vit-C 40 MG / Ferrous fumarate 191 MG / folate 1 MG / Niacinamide 3 MG / Polysaccharide iron complex 136 MG Oral Capsule
    • RxCUI: 999826 - ascorbic acid 40 MG / ferrous fumarate 191 MG / folic acid 1 MG / niacinamide 3 MG / polysaccharide iron complex 136 MG Oral Capsule [Integra F]
    • RxCUI: 999826 - Integra F (ascorbic acid 40 MG / ferrous fumarate 191 MG (iron 62.5 MG) / folic acid 1 MG / vitamin B3 3 MG / polysaccharide iron complex 136 MG (iron 62.5 MG)) Oral Capsule

    Which are the Pharmacologic Classes for Integra F?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".